Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ANKRD55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GRK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TWIST2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMPX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724314 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PLCD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSPY10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP290 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STXBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC85A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCRL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on